Munich, 20th june:
BioRN is the organizer of the EIT Health Catapult programme, which finals took place on the main stage at the Bits & Pretzels conference.
Merck, dedicated member of the BioRN Cluster, is one of the industry partners of the Catapult Prize Alliance – fast tracking Europe´s best Health startups and awarding their Catapult Emerging Biotech winner with the “MERCK Prize for the most promising Biotech”
Credit BioRN: Arantxa Encinas-Lopez, BioRN, Laura Koivusalo, StemSight
and Ann-Kathrin Übele, MERCK at the Bits&Pretzels HealthTech Conference
The prize includes a mentoring day at the M Lab™ facilities in Molsheim (France) where the award winner gets in touch with Merck’s technical experts for training, troubleshooting, or even small-scale experiments. A tour throughout the M Lab™ gives insights into production processes as well as systems and process equipment – a valuable source of inspiration for the entrepreneurs. No doubt this is one of the crucial opportunities for a start-up but also both for the EIT Health Catapult programme and Merck – to further boost the development of top-notch European Health Start-Ups . Congratulations to the StemSight - Vision Unlimited team around Laura Koivusalo, a finish biotech company that develops off-the-shelf cell therapies for unmet medical needs in corneal blindness. Connect with our colleague Arantxa Encinas-López to reach out for the latest developments in the European Health Start-Up Scene!
Contact:
Arantxa Encinas-Lopez
Start-up Project Manager
ae@biorn.org